GSTM1 and head and neck squamous cell carcinoma: The Hb trajectory can also explain why increasing the Hb level by transfusion or erythropoietin stimulation did not result in improved outcome for patients with low initial hemoglobin levels in head and neck squamous cell carcinoma [8].